Скачайте изображение (превью) выбрав качество

320x180 480x360 640x480 1280x720

Prof Giuseppe Rosano (St George's University Hospital, London, UK) discusses DAPA-HF.

Questions
1. Could you describe DAPA-HF in your own words and what the results tell us?
2. How does this complement existing SGLT2 data?
3. How should DAPA-HF influence clinical practice for use of SGLT2s in both diabetics and non-diabetics patients?
4. With increasing evidence of SGLT2 benefit what further is needed to influence prescribing habits in cardiology?

Filmed on site at ESC 2019 by Radcliffe Cardiology
Videography: Mike Knight & Tom Green / Interviewer: Liam O'Neill

See more videos here :
RC Academy :

radcliffecardiology.com is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide. Radcliffe Cardiology also has a dedicated eLearning platform, RC Academy, which uses innovative platforms to host digital webinars, live case broadcasts and video roundtable discussions.

Чтобы скачать видео "ESC 2019: DAPA-HF - A Perspective - Prof Giuseppe Rosano" передвинте ползунок вправо